Xencor, Inc. (NASDAQ: XNCR)
$23.7400
-0.2000 ( +0.25% ) 170.6K
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Market Data
Open
$23.7400
Previous close
$23.9400
Volume
170.6K
Market cap
$1.65B
Day range
$23.4250 - $24.1070
52 week range
$15.3100 - $27.2400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
8-k | 8K-related | 13 | Jun 14, 2024 |
8-k | 8K-related | 15 | Jun 13, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
10-q | Quarterly Reports | 81 | May 09, 2024 |